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Paratuberculosis is an infectious and incurable disease which
causes considerable economic losses in dairy cattle, due main-
ly to premature disposal and losses of milk production. In
1984 the Animal Health Service North-Netherlands started a
vaccination trial in which young calves were vaccinated once,
to test whether vaccination reduced the production losses and
whether the overall costs of vaccination were outweighed by
the benefits. Vaccination against paratuberculosis reduced the
number of clinically infected animals by almost 90 per cent. It
also reduced the numbers of subclinically infected animals
and animals with a positive histological and/or bacteriological
test result. Although vaccination did not prevent losses in milk
production, it reduced the infection pressure and the clinical
signs of the disease. Partial budgeting showed that vaccination
against paratuberculosis was highly profitable. The costs of
vaccination were us$15 per cow and the benefits (total returns
minus costs) were us$142 per cow.
PARATUBERCULOSIS is an infectious and incurable disease
which particularly affects cattle, sheep and goats. The bacterium
Mycobacterium paratuberculosis causes a thickening of the
intestinal lining which reduces the efficiency of feed absorption.
In the clinical form, paratuberculosis causes a considerable loss in
milk production and the cows lose weight in spite of the fact that
their appetite remains good. The disease manifests itself most
often in cows which are between four and five years old
(Benedictus 1985).
The animals most susceptible to the infection are young calves,
which can be infected by contact with manure or milk, or in utero
(Benedictus 1985). The severity of the infection depends primari-
ly on the age of the animal and the concentration of the pathogen
present. The older the animals and the lower the infection pres-
sure, the less often an infection will cause clinical signs of para-
tuberculosis (Benedictus 1985). When M paratuberculosis is
present on a farm, all the animals will usually come into contact
with it (Benedictus 1985).
Paratuberculosis causes considerable economic losses which
are due mainly to premature disposal and a reduction in milk pro-
duction. In dairy cattle, reductions in milk production were report-
ed to range from about 5 per cent in cows with subclinical forms
of the disease to 20 per cent in clinically affected cows. Moreover,
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affected cows were culled earlier and had a reduced slaughter
value. The average losses per animal culled were found to be
us$1250 and us$ 1000 for clinically and subclinically infected ani-
mals respectively (Benedictus and others 1987).
In the Netherlands, an eradication programme based on the vol-
untary disposal of infected cows was ineffective, and the number
of cases of paratuberculosis did not decline over the years. In
1984 the Animal Health Service North-Netherlands started a field
vaccination trial in which young calves were vaccinated once
(Kalis and others 1991). The goals of the trial were to investigate
the effect of vaccination on the numbers of animals with the clini-
cal or subclinical form of paratuberculosis, and to test whether
vaccination reduced the production losses and whether the bene-
fits of vaccination outweighed the overall costs. This article gives
the results of the cost-benefit analysis of the trial. A comparison
was made between the situation before and after vaccination, tak-
ing into account a vaccinated and a control group.
Materials and methods
Data
The vaccination trial was conducted on 12 farms in the northern
part of the Netherlands, where more than 5 per cent of cows were
culled anually as a result of paratuberculosis. The unvaccinated
cows which were culled between 1982 and 1984 were tested for
paratuberculosis. In 1984 the vaccination trial started and all the
calves on the farms were vaccinated once before one month of age
with a heat-killed water-in-oil emulsion vaccine. The vaccinated
animals left the farms between 1984 and 1992 and all those which
were culled were examined by the Animal Health Service for clin-
ical signs of paratuberculosis. Material from the intestines was
collected for histological, bacteriological and cultural tests to
check whether an animal was infected. The histological tests used
staining techniques and the material from the intestine was cul-
tured to investigate whether M paratuberculosis was present. The
presence ofM paratuberculosis was tested microscopically in the
animals which were positive in the histological or bacteriological
test and if the organism was identified the animals were consid-
ered to be subclinically infected. M paratuberculosis was often
not identified microscopically in animals with a positive cultural
test result and these animals were considered to be latently infect-
ed. After five years the rate of disposal of animals because of the
clinical form of paratuberculosis -was reduced from 11 per cent in
1984 to less than I per cent in 1989. However, the subclinical
form of the disease was still present to a considerable extent
(Kalis and others 1991).
Data on 652 cows were available for economic analysis. Data
on 573 cows, 304 of which were vaccinated and 269 of which
were unvaccinated controls, could be used to calculate the reduc-
tion in milk production. The cows from the vaccinated and control
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groups were subdivided into the following four groups on the
basis of clinical and laboratory tests:
(a) healthy, uninfected animals in which no bacteria were found;
(b) subclinically infected animals which tested positive for para-
tuberculosis in the bacteriological and/or histological test,
but which had no clinical signs;
(c) animals with clinical signs of paratuberculosis which were
confirmed by laboratory tests and were culled;
(d) latently infected animals which were positive only in the cul-
tural tests, and which were free of clinical signs.
In the vaccinated group the numbers of animals in groups a, b, c
and d were 162, 27, 18 and 97 respectively, and in the unvaccin-
ated group the numbers were 124, 45, 50 and 50.
The empirical data were evaluated statistically with Statistix 4.0
(Siegel 1992) and tested for significance by the least significant
difference method, with P<0-05.
Cost-benefit analysis
The possible benefits of vaccination for the farmer would be
reduced culling and lower losses in production. However, the
farmer must meet higher costs for vaccination and sampling.
The costs and benefits of vaccination were calculated by partial
budgeting, which meant that only the changes produced by the
vaccination programme were calculated. The economic losses for
each animal consisted of the following components (Dijkhuizen
and others 1991): first, the losses before disposal, which consist of
the reduction in milk production and the costs of examination and
treatment; secondly, the losses at disposal, which consist of the
lower slaughter value and the costs of open places; and thirdly, the
loss due to disposal, which is the loss of future income.
The sum of these components gives the total losses per animal
at farm level. The benefits of vaccination will be the reduction in
the losses due to one or more of these components.
Results
Losses before disposal
The production of milk, fat and protein in the cows' last lacta-
tion before disposal and in their first (heifer) lactation were com-
pared, after adjustment for differences in age, season, year and
length of lactation (Wilmink 1987). This calculation gave the loss
or gain in milk production for a cow in its last lactation compared
with its expected milk production capacity as a heifer. The per-
centage reduction in milk production multiplied by the average
production of heifers of the corresponding subgroup gives the
absolute reduction in kg of milk, fat and protein. The results for
the subgroups are summarised in Table l.
In the subgroup of uninfected animals the vaccinated animals
had a greater reduction in milk production than the unvaccinated
animals, 316 kg compared with 28 kg of milk. In the subgroups of
subclinically and latently infected animals the vaccinated animals
also had a greater reduction in milk production, respectively 706 -
199 = 507 kg and 382 - (-248) = 630 kg. However, the vaccinated
clinically infected animals had a smaller reduction in milk produc-
tion, 1089 - 631 = 458 kg milk, than the unvaccinated animals. In
each group, similar trends were apparent for the reduction in the
production of fat and protein.
The costs of examination and treatments included the visit by
a veterinarian at a rate of about us$20 and possible faeces
and blood tests costing about us$5. Some animals were also
treated for scour at an average cost of us$3. The total costs were
estimated to be us$25 per clinically infected cow. The costs of
vaccination were us$15 per animal.
Losses at disposal
Clinically infected animals had a lower slaughter value at dis-
posal, owing to weight losses, which was estimated at about 30
per cent. Considering a normal slaughter value of us$1085 per
culled cow, this loss was us$325 per clinically infected cow.
According to Benedictus and others (1987), replacement animals
will not always be available immediately, and a cost of us$47 was
therefore assumed for two weeks of open places per culled cow.
Losses due to disposal
The economic losses due to premature disposal can be defined
as the difference between the income a particular animal could
earn during its remaining expected life, and the expected income
over the same period of a replacement animal. These losses vary,
particularly with the productive quality of the cow and her age at
disposal, and were taken from the dynamic programming model
of Houben and others (1994). The cows in the various subgroups
produced on average 6-5 per cent above herd level in their first
lactation and were culled on average after 3-3 lactations. The
losses due to disposal averaged us$815 per case, and ranged from
us$614 for vaccinated, latently infected cows to us$919 for
unvaccinated, clinically infected cows (Table 2).
Profitability of vaccination
The profitability of vaccination is the difference in costs before,
at and due to disposal, compared with the unvaccinated group.
The total costs for the vaccinated and unvaccinated groups were
determined by multiplying the frequency of uninfected, subclini-
cally, clinically and latently infected animals in each group by the
costs at each stage. The costs of disposal of an average cow from
the unvaccinated and vaccinated group are the standard of com-
parison. It was assumed that the total rate of disposal at farm level
remained the same. The total losses calculated for the periods
before, at, and due to disposal are summarised in Table 2.
As might be expected the total losses were highest for clinically
infected cows. Vaccination reduced the losses for these animals
by us$106 per cow. For subclinically and latently infected cows
the opposite occurred; in the case of subclinically infected cows,
mainly because of a high lost future income, and in the case of
latently infected cows because of a greater reduction in milk pro-
duction before disposal. The total losses for uninfected animals
were lower, despite a greater reduction in milk production,
TABLE 1: Reductions in milk, fat and protein production (% and kg)
Uninfected Subclinically infected Clinically infected Latently infected
unvaccinated vaccinated unvaccinated vaccinated unvaccinated vaccinated unvaccinated vaccinated
Number of cattle 124 162 45 27 50 18 50 97
Milk
(%) 0.5 57 3.9 13.1 20.6 13.1 -45 7.0
(kg) 28 316 199 706 1089 631 -248 382
Fat(N) 06 49 2.0 13.5 13.2 14.2 -4.1 7.9
(kg) 1.5 12.2 4.5 32-7 29.7 32.4 -10.1 19.5
Protein
(%) -1.2 4.2 2.0 13.5 21-8 13.6 -5.3 5.3
(kg) -2.3 7.9 3.4 250 334 23.3 -9.8 9.9
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TABLE 2: Total losses (us$) before, at, and due to disposal per subgroup
Uninfected Subclinically infected Clinically infected Latently infected
unvaccinated vaccinated unvaccinated vaccinated unvaccinated vaccinated unvaccinated vaccinated
Number of cattle 124 162 45 27 50 18 50 97
Before disposal
(%) -14 42 44 352 407 363 -96 139
At disposal 47 47 47 47 47 47 47 47
Due to disposal 831 624 831 907 919 857 768 614
Total 864 713 922 1306 1698 1592 719 800
because of a smaller lost future income. Clinically infected ani-
mals had a smaller reduction in milk production and a smaller lost
future income, which also resulted in smaller losses for clinically
infected animals in the vaccinated group.
In Table 3 the costs per subgroup have been multiplied by the
number of animals in the unvaccinated and vaccinated groups.
Vaccination against paratuberculosis decreased the frequency of
subclinically and clinically infected animals. In the unvaccinated
group 26 per cent and 11 per cent of the animals were subclinical-
ly and clinically infected, respectively, whereas in the vaccinated
group the percentages were 11 per cent and 0-8 per cent, respec-
tively. This means a reduction of 86 per cent in the numbers
of clinically infected animals. The number of latently infected
animals increased considerably from 15 to 26 per cent. However,
the number of uninfected animals increased after vaccination from
48 to 62 per cent.
Taking into account the frequency distribution shown in Table
3, the total losses were us$949 per cow in the unvaccinated group
and us$807 in the vaccinated group. The benefits of vaccination,
that is the total retums minus the costs, were on average us$142
per culled cow. It is true that the costs for the uninfected and
latently infected cows were higher in the vaccinated group
(us$444 and us$210 respectively versus us$410 and us$111 in
the unvaccinated group), but the frequency of subclinically and
clinically infected animals was considerably lower in the vacc-
inated group, which is the major reason that vaccination was
profitable.
Discussion
Paratuberculosis is difficult to diagnose in the various stages of
the disease (Sprangler and others 1992) and a combination of tests
was used to increase the reliability of detection.
The unvaccinated and vaccinated groups were made compara-
ble for age, calving season, month of lactation, and lactation
length by correcting the lactations by factors derived from the
Dutch Cattle Syndicate (NRS) (Wilmink 1987). Nevertheless it has
not been proved that all the differences in milk production and
lost future income could be explained by an infection with paratu-
berculosis. Among the uninfected animals there were differences
in costs between the unvaccinated and vaccinated group; the loss-
es due to lost future income should be interpreted with caution.
Benedictus and others (1987) observed a reduction in milk pro-
TABLE 3: Costs per average culled animal
Cows per Total costs per Average
subgroup (%) cow (us$) costs within
(see Table 2) group (us$)
Unvaccinated
uninfected 47-5 864 410
subclinically infected 261 922 241
clinically infected 11-0 1698 187
latently infected 15.4 719 i11
total 100 949
Vaccinated
uninfected 62.3 713 444
subclinically infected 10.7 1306 140
clinically infected 0.8 1592 13
latently infected 26-2 800 210
total 100 807
duction of 16 per cent in subclinically infected animals whereas,
in this investigation, the reduction was only 4 per cent in the
unvaccinated group and 13 per cent in the vaccinated group. One
explanation might be that the subclinically infected animals used
by Benedictus and others (1987) were at a later, almost clinical,
stage of the disease. The 20.5 per cent reduction in milk produc-
tion for the clinically infected animals was similar to the 19-5 per
cent observed by Benedictus and others (1987). The 13 per cent
reduction in the milk production of the vaccinated clinically
infected animals may not have been due entirely to the vaccina-
tion. These animals were culled, on average, before their third
lactation, that is before the influence of paratuberculosis on milk
production reaches its maximum (Collins and Nordlund 1991).
The vaccination of the uninfected and latently infected animals
appeared to reduce their milk production by 5-7 per cent and 7-0
per cent, respectively, whereas there was hardly any reduction in
the uninfected (0-6 per cent) and latently infected (-4.5 per cent)
cows in the unvaccinated group. The reduction in milk production
in the vaccinated group may have been due to the fact that older
animals, like heifers, can still experience an infection with M
paratuberculosis without getting the clinical form when they are
older (Rossiter and others 1994). The vaccinated heifers which
were infected may not have had any difficulty in resolving the
infection and remaining uninfected or becoming latently infected,
unlike the unvaccinated heifers, which may have had more diffi-
culty in resolving an infection, and suffered a reduction in milk
production. As a result, the vaccinated heifers had a higher milk
production than the unvaccinated heifers (C. H. J. Kalis, personal
communication). The correction of the last lactation of a vaccinat-
ed, uninfected or latently infected cow in relation to its lactation
as a heifer thus seems to result in a greater reduction in milk pro-
duction in the vaccinated group.
Vaccination did not seem to reduce the incidence of infection
with M paratuberculosis, as was shown by the large number of
latently infected animals in the vaccinated group. However, vacci-
nation did reduce the incidence of severe clinical infections.
Subclinically and clinically infected animals had much higher
costs than latently infected animals, us$203 and us$979 respec-
tively, in the unvaccinated group, and us$506 and us$792 respec-
tively, in the vaccinated group. Since vaccination reduced the
incidence of subclinically and clinically infected animals consid-
erably, the eradication of paratuberculosis would be highly prof-
itable, and vaccination could contribute to the process.
On the farms used in this investigation 11 per cent of the ani-
mals were clinically infected before vaccination. Even if the level
of infection had been only 5 per cent, the benefits of vaccination
would still have been us$83 per head.
Farms that vaccinate are not allowed to export live animals.
The calculated benefits of vaccination will, however, on average
easily outweigh the potential losses from such a restriction. For
example, if 10 per cent of the heifers were exported at an average
price of us$1390, then the us$142 benefit from vaccination would
outweigh the losses from the export restrictions.
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Short Communications
Synovial sarcoma in a ferret
M. H. Lloyd, C. M. Wood
Veterinary Record (1996) 139, 627-628
A-TWO-and-a-half year old stock male fitch ferret (Mustela
putorius furo), kept group housed in an enriched environment for
biomedical research, presented with an abnormal gait. This was
found to be caused by a swelling 4 cm across and 6 cm long
around the right stifle joint, which had apparently developed over
a 48-hour period.
On clinical examination, the animal was otherwise well. There
was no evidence of respiratory or cardiovascular disease, and no
loss of weight or condition. Recent screening indicated the animal
was free from Aleutian disease virus. The swelling was firm,
immobile and apparently not painful. It extended to the distal third
of the tibia and proximally to the middle of the femur. It thus pre-
vented movement of the stifle joint, although the animal was able
to move around by swinging the leg out from the hip joint to com-
pensate.
The animal was sedated with 100 jig/kg medetomidine given by
intramuscular injection (Domitor; SmithKline Beecham Animal
Health), and radiographs were taken of the swelling (Fig 1). These
showed a circular mass with soft tissue density centred around the
proximal tibia, and a second ovoid mass extending from the stifle
to the distal tibia. Two areas of mineral density were visible with-
in the soft tissue masses. There was sclerosis in the proximal tibia,
particularly in the epiphysis, and increased density within the
medulla with loss of the corticomedullary junction, extending to
the proximal third of the tibia. In the region of the tibial crest,
there was periosteal new bone giving a 'sunburst' effect, with
areas of marked sclerosis caudal to this. No radiographic changes
were visible in the distal femur, and the joint space was clear.
A diagnosis of malignant neoplasia arising from the proximal
tibia was made on the basis of these clinical and radiological find-
ings. The animal was euthanased and a post mortem examination
carried out. Examination of the chest cavity revealed numerous,
well defined white foci within the parenchyma of the lungs. The
swelling on the leg consisted of a well encapsulated mass of firm,
pale tissue with two lobes: a spherical part around the joint, with
an oval part extending distally down the tibia. The bony pathology
in the proximal tibia was visible grossly within this mass (Fig 2).
No other abnormalities were present.
Histological examination of the mass around the joint revealed
that it consisted of broad sheets of dark-staining epithelioid cells
FIG 1: Lateral
radiograph of right
stifle. Note marked
soft tissue swellings,
radiodense foci, scle-
rosis and sunburst
effect in proximal
tibia
separated by wide bands of fibro-collagenous tissue. There were
also clusters and short rows of epithelioid cells ranged alongside
small clefts and interspersed by narrow bands of fibrous tissue
(Fig 3). In a few areas there were scattered single epithelioid cells
within fibrous tissue. The epithelioid cells had clearly defined cell
borders and dark-staining, sometimes vacuolated, cytoplasm. The
broad sheets of cells were anaplastic with nuclear pleomorphism
and many mitotic figures. Giant cells and multinucleate cells were
also present. The fibro-collagenous tissue included large pale-
staining cells with fibrillar cytoplasm and uniform nuclei with
very few mitoses. Sheets of anaplastic epithelioid cells were infil-
trating periosteum and bone and there was associated non-neoplas-
tic new bone formation and periosteal and cartilage hyperplasia in
these areas. The tumour also appeared to be expanding into the
surrounding subcutaneous connective tissue and was bordered by
a capsule of the fibrous tissue component. These findings were
consistent with a diagnosis of synovial sarcoma.
The lesions in the lungs were those of focal histiocytosis, con-
sisting of accumulations of foamy macrophages with multinucle-
ate giant cells, cholesterol clefts and lymphocytes. There was no
evidence of tumour metastasis.
Spontaneous neoplasms in ferrets have been reported as being
rare, although the incidence is hard to determine. Several authors
have postulated that the paucity of reports is due to the relatively
short lifespan of ferrets in the laboratory, but there is no increase
in incidence in pet or zoo ferrets which are longer lived
(Dillberger and Altman 1989). Others have suggested a genetic
resistance to neoplasia, but reviews of pathological findings in fer-
rets have shown that neoplastic diseases have been reported in all
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